Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-04-08 Sale |
2024-04-10 8:50 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
26,270 | $246.19 | $6,467,491 | 1,047,531 (Indirect Direct) |
View |
2024-04-03 Sale |
2024-04-05 8:50 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
73,730 | $243.93 | $17,984,804 | 1,612,789 (Indirect Direct) |
View |
2021-07-21 Sale |
2021-07-23 4:51 pm |
ALEXION PHARMACEUTICALS INC. | ALXN | FRIEDMAN PAUL A Director |
12,840 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-25 Option Award |
2024-06-27 9:41 pm |
N/A 2031-06-25 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
1,819 | $0 | 843,094 (Direct) |
View |
2024-06-14 Option Award |
2024-06-18 4:13 pm |
N/A 2034-06-13 |
Prelude Therapeutics Inc | PRLD | FRIEDMAN PAUL A Director |
23,500 | $0 | 23,500 (Direct) |
View |
2024-04-08 Exercise |
2024-04-10 8:50 pm |
N/A 2026-07-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
26,270 | $0 | 1,047,531 (Direct) |
View |
2024-04-08 Exercise |
2024-04-10 8:50 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
26,270 | $9.45 | 1,047,531 (Direct) |
View |
2024-04-03 Exercise |
2024-04-05 8:50 pm |
N/A 2026-07-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
73,730 | $0 | 1,612,789 (Direct) |
View |
2024-04-03 Exercise |
2024-04-05 8:50 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
73,730 | $9.45 | 1,612,789 (Direct) |
View |
2023-01-16 Tax Withholding |
2024-01-18 1:47 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Director |
2,254 | $243.92 | 841,275 (Direct) |
View |
2023-06-16 Option Award |
2023-06-21 4:14 pm |
N/A 2033-06-15 |
Prelude Therapeutics Inc | PRLD | FRIEDMAN PAUL A Director |
23,500 | $0 | 23,500 (Direct) |
View |
2023-01-16 Option Award |
2023-01-18 8:00 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Chief Executive Officer |
26,668 | $0 | 843,529 (Direct) |
View |
2022-06-17 Option Award |
2022-06-22 4:14 pm |
N/A 2032-06-16 |
Prelude Therapeutics Inc | PRLD | FRIEDMAN PAUL A Director |
34,300 | $0 | 34,300 (Direct) |
View |
2022-02-22 Option Award |
2022-02-24 8:10 pm |
N/A 2032-02-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Chief Executive Officer |
70,000 | $0 | 70,000 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 5:41 pm |
N/A 2031-06-17 |
Prelude Therapeutics Inc | PRLD | FRIEDMAN PAUL A Director |
23,344 | $0 | 23,344 (Direct) |
View |
2021-05-20 Option Award |
2021-05-24 4:34 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | FRIEDMAN PAUL A Director |
2,495 | $0 | 12,840 (Direct) |
View |
2021-02-22 Option Award |
2021-02-23 1:35 pm |
N/A 2031-02-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Chief Executive Officer |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2020-09-24 7:20 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | FRIEDMAN PAUL A Director |
0 | $0 | 546,786 (Direct) |
View |
2020-05-26 Option Award |
2020-05-28 4:27 pm |
N/A 2030-05-25 |
INCYTE CORP | INCY | FRIEDMAN PAUL A Director |
11,796 | $0 | 282,327 (Direct) |
View |
2020-05-14 Option Award |
2020-05-18 5:12 pm |
N/A N/A |
ALEXION PHARMACEUTICALS INC. | ALXN | FRIEDMAN PAUL A Director |
3,468 | $0 | 10,345 (Direct) |
View |